Navigation Links
Sanofi-aventis Delivers 2008 Results Above Guidance
Date:2/11/2009

705 +9.9% 6,143 +15.3%

Full-year 2008 sales of Plavix(R) in the United States (consolidated by BMS) were sharply higher than in 2007, when sales were affected by competition from a generic version in the early part of the year. In Europe, the product's 3.2% growth rate reflected competition from several clopidogrel besylates in the monotherapy segment since August in Germany, where the market share of Plavix(R)/Iscover(R) by volume remained around 75% in December (IMS Pharmatrend, week commencing December 22, 2008). In the "Other Countries" region, growth for Plavix(R) benefited from its success in Japan, where net sales reached EUR 67 million in the fourth quarter of 2008 (vs. EUR 33 million in the fourth quarter of 2007) and EUR 182 million over 2008 as a whole (vs. EUR 66 million in 2007).

Worldwide presence(1) of Aprovel(R)/Avapro(R)/Karvea(R)

    EUR million                        Change on a            Change on a
                                       comparable             comparable
                                Q4 2008    basis     FY 2008     basis
    Europe                        250        +9.2%     992        +8.8%
    United States                 140        +2.2%     499        +6.4%
    Other Countries               120        +4.3%     475       +20.6%
    TOTAL                         510        +6.0%   1,966       +10.8%

Despite a very competitive environment, worldwide sales of Aprovel(R) achieved double-digit growth in 2008.

(1) See appendix 7 for a definition of financial indicators

In September 2008, the Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion on the authorization of a generic of irbesartan as a monotherapy in Europe. However, the active ingredient of
'/>"/>

SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. Sanofi-aventis Partners with the Hispanic Community in Bronx to Increase Health Awareness, Access to Resources and Help Improve Patient Care
2. Sanofi-aventis Partners with the African American Community in Memphis to Increase Health Awareness, Access to Resources and Help Improve Patient Care
3. Sanofi-aventis U.S. Announces Increased Access to Drugs for Low Income Patients Through Expanded PAP Programs
4. Sanofi-aventis Partners with the African American Community in Baltimore to Increase Health Awareness, Access to Resources and Help Improve Patient Care
5. Welvista Announces Partnering with sanofi-aventis U.S. to Provide Medication at No Cost to the Uninsured
6. Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1):
7. Sanofi-aventis Teams With HHS Quality Agency to Distribute Consumer Health Materials
8. Sanofi-aventis Named One of Best Employers for Healthy Lifestyles by National Business Group on Health
9. Sanofi-aventis: Encouraging First-Quarter 2008 Results Further Positive Phase III Results for Eplivanserin
10. TechTeam Global Will Provide Multilingual EDC Support Services for sanofi-aventis recherche & developpement
11. Sanofi-aventis Announces 2007 Earnings Ahead of Guidance Sharp Rise in Proposed Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Francisco, September 15, 2014A prospective study that compared ... patients with bone metastases demonstrates that single fraction ... multiple fraction radiation therapy (MFRT) when pain, function ... research presented today at the American Society for ... study indicates that improvements in patients, pain, function ...
(Date:9/16/2014)... 16, 2014 Fresh shiitake mushrooms ... and potassium. They are second-most consumed mushroom worldwide, ... their healing and health properties. , In addition ... can stimulate and strengthen the immune system and ... polycharrides, including beta glucans . These medicinal ...
(Date:9/16/2014)... 16, 2014 Synergy Research Group has ... gives the best detail and analysis of the state ... a variety of sources, including Ministry of Health in ... will give readers actionable intelligence on clinical trials in ... relied on by the local and international life science ...
(Date:9/16/2014)... Wholelifeinsurancecompanies.org has released a new blog post ... bad heart condition. , Clients who have a bad ... they compare quotes. Most agencies will insure applicants who ... actual and past medical condition. , If someone ... in the past, his or her chances of finding ...
(Date:9/16/2014)... had children (parous women) appear to have an ... the subtype that carries a higher mortality rate ... ancestry. A similar relationship was found for ... and increased risk of estrogen receptor-negative and triple-negative ... who had never breastfed. These findings, published in ...
Breaking Medicine News(10 mins):Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 2Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 3Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 4Health News:As Fall Schedules Settle In, Block Stress-Related Illness with Your Own Shiitake Mushroom Log Kit from Lost Creek Mushroom Farm 2Health News:As Fall Schedules Settle In, Block Stress-Related Illness with Your Own Shiitake Mushroom Log Kit from Lost Creek Mushroom Farm 3Health News:Synergy Research Group Debuts Ukraine Orange Paper 2Health News:No Exam Life Insurance for Clients Who Have a Bad Heart Condition! 2Health News:Lactation linked to reduced estrogen receptor-negative, triple-negative breast cancer risk 2
... cells in the human brain is linked to learning and ... Florida. The research is the first to show such a ... upcoming print issue of the journal Brain , provide ... and reveal potential cellular targets for drug therapy. The ...
... HealthDay Reporter , WEDNESDAY, Aug. 25 (HealthDay News) -- ... 2008, nearly one in four American parents with health insurance ... to access the medical care their children needed. Parents ... likely than others to say their insurance coverage did not ...
... Despite the fact that an estimated 25 million ... general anesthesia, scientists have only been able to hypothesize ... They previously thought that the processes of "going under" ... the same way. Now, researchers at the University of ...
... Va.SNM supports the U.S. Senate in its introduction of ... and Radiation Therapy Act of 2010 (CARE Act), S. ... by Sen. Mike Enzi [R-WY], aims to ensure that ... are set at the state level. The bill,s co-sponsors ...
... Melissa Lee Phillips HealthDay Reporter , WEDNESDAY, Aug. ... to an inheritable eye disease that affects 5 percent of ... for transplants of the cornea. The genetic disorder, ... the cornea -- the thin, clear membrane that covers the ...
... Reporter , WEDNESDAY, Aug. 25 (HealthDay News) -- U.S. ... U.S. judge to halt any expansion of stem cell ... basically blindsided the scientific community, effectively takes embryonic stem ... when then-President George W. Bush ordered that federal monies ...
Cached Medicine News:Health News:Scientists find link in humans between nerve cell production, memory 2Health News:Scientists find link in humans between nerve cell production, memory 3Health News:Even Before Recession, 14 Million Kids 'Underinsured': Study 2Health News:Even Before Recession, 14 Million Kids 'Underinsured': Study 3Health News:Penn study sheds light on how the brain shifts between sleep/awake states under anesthesia 2Health News:SNM applauds US Senate's introduction of CARE Act 2Health News:Study Links Gene to Serious Eye Disease 2Health News:Obama to Appeal Stem Cell Ruling 2Health News:Obama to Appeal Stem Cell Ruling 3
(Date:9/16/2014)... 16, 2014  Formex, LLC ("Formex"), a ... Mr. Greg Weilersbacher joined Formex as Director of ... Greg Weilersbacher has over ... expertise in Quality Assurance, Facility Validation, GMP ... brings to Formex a diverse wealth of ...
(Date:9/16/2014)... RICHMOND, Va. , Sept. 16, 2014 /PRNewswire-USNewswire/ ... (NAMCP) Medical Directors Institute has simultaneously released the ... the NAMCP Medical Diagnostics Dossier Template © , ... dossier template formats for either medical devices or ... unique aspects of each of these technology types ...
(Date:9/16/2014)... Northwest Biotherapeutics (NASDAQ: NWBO ) ... therapies for solid tumor cancers, announced today that its ... as a "Promising Innovative Medicine" (PIM) under the new ... UK in April 2014.  A PIM is the first ... under the EAMS.  The PIM designation ...
Breaking Medicine Technology:Greg Weilersbacher Joins Formex, LLC As Director of Quality Assurance and Quality Control 2NAMCP Medical Directors Institute releases NAMCP Medical Technologies and Diagnostics Dossier Templates to provide model approach for medical devices or diagnostics 2NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 2NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 3NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 4NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 5
... Sept. 20, 2011 TheraVasc ( www.theravasc.com ) announced the ... drug, TV1001, to diabetic patients. The trial included 12 diabetic ... oral formulations of TV1001, an enteric coated and a non-enteric ... drug.  Based on prior studies conducted in animals, the circulating ...
... American Medical Systems (AMS), a leading provider of world-class ... today announced the launch of a new consumer friendly website ... partners learn how penile prosthetic implants can restore sexual function ... the popularity of ED medications, these drugs fail to resolve ...
Cached Medicine Technology:TheraVasc Releases Phase I Trial Data Demonstrating Safety of Drug in Diabetic Patients 2New Website Provides Comprehensive Resource to Anyone With Erectile Dysfunction 2New Website Provides Comprehensive Resource to Anyone With Erectile Dysfunction 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: